Article
Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinoma
2022-03-30
Abstract excerpt
<h4>Background: </h4> Resistance to targeted therapies represents a major hurdle to successfully treat hepatocellular carcinoma (HCC). While epigenetic abnormalities are critical determinants of HCC relapse and therapeutic resistance, the underlying mechanisms are poorly understood. We aimed to address whether and how dysregulated epigenetic regulators have regulatory and functional communications in establishing...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a7041ef8-216b-5f98-a6dd-f225efcd57c4
- DOI
- 10.21203/rs.3.rs-1432174/v2
